26-Year-Old Beats Stage 3 Cancer With New Immunotherapy

Mrinali Dhembla was planning her wedding and dreaming about her future when doctors told her she had Stage 3 rectal cancer that had already spread to her spine. At just 26 years old, the diagnosis felt impossible.

"I still remember the doctor telling me that I had cancer, and my first instinct was to say that he was wrong," Dhembla recalled. "I said, 'That's not possible. I'm just 26 years old.'"

After months of aggravating back pain and crushing fatigue, genetic testing revealed Dhembla had Lynch syndrome, the most common cause of hereditary colorectal cancer. People with this condition have mutations that prevent their genes from fixing DNA errors properly, making them vulnerable to cancer at younger ages.

But Dhembla's Lynch syndrome became her advantage. Her doctors at Northwell Cancer Institute selected her as one of the first patients to receive a revolutionary dual immunotherapy treatment.

"Patients that have Lynch syndrome are excellent candidates for immunotherapy," explained Dr. Nicholas Hornstein, one of Dhembla's oncologists. "Because they have so many mutations in their cancer cells, it allows their immune system to recognize them, and they just need a little bit of a boost with immunotherapy to become effective at eradicating their tumors."

The treatment worked by releasing the brakes on Dhembla's immune system, letting her body fight the cancer naturally. Instead of enduring months of debilitating chemotherapy and radiation, she received just three infusions over four months.

The results stunned even her doctors. Dhembla felt strong enough to run a 5K during her treatment period, a feat unimaginable with traditional cancer therapies.

Why This Inspires

In July 2025, Dhembla was declared cancer-free. Since then, she's taken three trips and resumed planning her wedding, reclaiming all the life moments cancer threatened to steal.

Dr. Hornstein shared the long-term promise of this approach. "The benefit we see from immunotherapy can last for decades. Patients who are able to eradicate their tumors, they tend to stay gone."

Dhembla's experience comes as colorectal cancer rates among younger Americans continue rising. Cases have increased 2.3% among people in their 40s since the 1990s, making early detection more critical than ever.

Now cancer-free, Dhembla has one urgent message for others: "Just listen to your body. If you're having symptoms, if you're sensing something unusual, just please go to a doctor."

Her story proves that even the scariest diagnosis can have a hopeful ending when medical innovation meets the power of the human immune system.